Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Swallow this: new pill thermometer could replace probes

NCT ID NCT02910479

Knowledge-focused Sponsor: University Hospital, Caen Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a new device called E-Celsius, which is a pill you swallow that measures your body temperature as it travels through your digestive tract. Researchers compared its readings to standard thermometers placed in the rectum or esophagus in 22 healthy volunteers. The goal was to see if the pill is a reliable and comfortable alternative for tracking body temperature.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
E-Celsius ingestible temperature capsule (device)
What this could lead to
If successful, this could provide a more convenient and continuous way to measure body temperature without wires or probes.
What could go wrong
This is a small early-phase study in healthy people, so results may not apply to sick patients. The capsule may not be as accurate as standard methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 1

The first testing in people. Mainly checks safety and dose, usually in a small group.

Participants

22 people

The number who actually took part.

Start date

Nov 2015

Finished

Mar 2016

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 59 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Healthy volunteers male or female (18 to 59 years inclusive) * Signed the informed consent. * Affiliated to the social security scheme * French speaker Exclusion Criteria: * Subject having started or stopped during the 15 days preceding the inclusion visit one of the following treatments: antidepressants, anxiolytics, antiparkinsonian agents, neuroleptics. * Subject having taken over the previous 7 days a drug to treat irritable bowel syndrome (antispasmodic, etc ...) or constipation (laxative) * Subject with known food allergies * Subject undergoing surgery for colon surgery * Subject with an organic occlusion * Subject with known abnormal liver or renal function * Subject participating in another clinical study within a month before the inclusion visit. * A person with a bodyweight under 40 kg * Any person with obstruction (known or suspected) of the gastrointestinal tract, including people with diverticula (folds) intestinal or intestinal inflammation known. * People with a BMI greater than or equal to 30. * People under guardianship * People who have or had known swallowing disorders * People who have to undergo an MRI or to be subjected to a strong magnetic field programmed during the transit of the capsule * Persons equipped with a pacemaker * People with diabetes or with diabetic history * People with heave * The detainees * Pregnant women * People with nasal septum deviation * People with against-indications to the placement of an esophageal tube: people who carry chronic esophageal pathology (eg, gastroesophageal reflux treated, hiatal hernia,)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy volunteers are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Healthy volunteers

Contacts and locations

Locations

  • Caen University Hospital

    Caen, 14033, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.